StudyManager today announced that Meagan Medical, Inc., a clinical research and product development company, has deployed StudyManager Evolve software to manage its latest clinical study.
“We are seeing more and more Evolve interest in the medical device market and are pleased that our Evolve software will help play a key role in Meagan Medical’s study,” said Jeff West, Director, Professional Services, StudyManager. “ It’s been exciting to work with the Meagan Medical team from startup, helping ensure the study stayed on track.”
Evolve's Web-based interface integrates clinical trial management and electronic data capture tools. These features are extremely scalable, and can be used together seamlessly or independently. Evolve enables users to create a single, centralized and secure location for key study information, simplifying study operations and enhancing team efficiency.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.